A detailed history of Gofen & Glossberg LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gofen & Glossberg LLC holds 375,818 shares of PFE stock, worth $9.48 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
375,818
Previous 378,337 0.67%
Holding current value
$9.48 Million
Previous $16.6 Million 16.31%
% of portfolio
0.49%
Previous 0.47%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023

SELL
$41.75 - $54.5 $105,168 - $137,285
-2,519 Reduced 0.67%
375,818 $19.3 Million
Q3 2022

Oct 13, 2022

SELL
$43.76 - $53.42 $28,400 - $34,669
-649 Reduced 0.17%
378,337 $16.6 Million
Q2 2022

Jul 14, 2022

SELL
$46.53 - $55.17 $175,418 - $207,990
-3,770 Reduced 0.98%
378,986 $19.9 Million
Q1 2022

Apr 14, 2022

SELL
$45.75 - $56.69 $353,739 - $438,327
-7,732 Reduced 1.98%
382,756 $19.8 Million
Q4 2021

Jan 25, 2022

SELL
$41.32 - $61.25 $223,375 - $331,117
-5,406 Reduced 1.37%
390,488 $23.1 Million
Q3 2021

Oct 13, 2021

SELL
$39.25 - $50.42 $14,797 - $19,008
-377 Reduced 0.1%
395,894 $17 Million
Q2 2021

Jul 13, 2021

SELL
$35.91 - $40.68 $564,612 - $639,611
-15,723 Reduced 3.82%
396,271 $15.5 Million
Q1 2021

Apr 13, 2021

SELL
$33.49 - $37.77 $1.65 Million - $1.86 Million
-49,276 Reduced 10.68%
411,994 $14.9 Million
Q4 2020

Jan 15, 2021

SELL
$33.47 - $42.56 $558,380 - $710,028
-16,683 Reduced 3.49%
461,270 $17 Million
Q3 2020

Oct 09, 2020

BUY
$31.75 - $37.25 $952,944 - $1.12 Million
30,014 Added 6.7%
477,953 $17.5 Million
Q2 2020

Jul 13, 2020

BUY
$30.12 - $36.54 $241,411 - $292,868
8,015 Added 1.82%
447,939 $14.6 Million
Q1 2020

Apr 14, 2020

SELL
$27.03 - $38.62 $167,694 - $239,598
-6,204 Reduced 1.39%
439,924 $14.4 Million
Q4 2019

Jan 28, 2020

SELL
$32.92 - $37.36 $522,605 - $593,090
-15,875 Reduced 3.44%
446,128 $17.5 Million
Q3 2019

Oct 10, 2019

BUY
$32.49 - $42.13 $193,185 - $250,504
5,946 Added 1.3%
462,003 $16.6 Million
Q2 2019

Jul 12, 2019

SELL
$36.98 - $41.52 $250,687 - $281,464
-6,779 Reduced 1.46%
456,057 $19.8 Million
Q1 2019

Apr 11, 2019

SELL
$37.5 - $41.2 $360,562 - $396,138
-9,615 Reduced 2.04%
462,836 $19.7 Million
Q4 2018

Jan 15, 2019

BUY
$38.47 - $43.86 $352,385 - $401,757
9,160 Added 1.98%
472,451 $20.6 Million
Q3 2018

Oct 11, 2018

SELL
$34.47 - $41.81 $113,751 - $137,973
-3,300 Reduced 0.71%
463,291 $20.4 Million
Q2 2018

Jul 11, 2018

SELL
$32.98 - $35.16 $281,517 - $300,125
-8,536 Reduced 1.8%
466,591 $16.9 Million
Q1 2018

Apr 11, 2018

SELL
$31.91 - $37.02 $160,507 - $186,210
-5,030 Reduced 1.05%
475,127 $16.9 Million
Q4 2017

Jan 11, 2018

BUY
$33.26 - $35.29 $106,864 - $113,386
3,213 Added 0.67%
480,157 $17.4 Million
Q3 2017

Nov 16, 2017

SELL
$31.0 - $34.15 $149,947 - $165,183
-4,837 Reduced 1.0%
476,944 $17 Million
Q2 2017

Aug 16, 2017

BUY
N/A
481,781
481,781 $16.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $142B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.